Market revenue in 2023 | USD 252.5 million |
Market revenue in 2030 | USD 477.2 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Type a |
Fastest growing segment | Type A |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Type A, Type B |
Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.65% in 2023. Horizon Databook has segmented the Argentina botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
Argentina ranks fourth after Brazil, Mexico, and Colombia in the facial injectable market. Like other business sectors in Argentina, the esthetic market has been negatively impacted due to the financial crisis, leading to low spending power and depressed consumer sentiments. Argentina’s currency declined by 25% in 2019.
however, it is considered to be one of the emerging markets by WHO. According to Theodora, 39.6% of the population in the country is aged between 25 and 54, and life expectancy has improved. For many years, the esthetic industry in Argentina remained stagnant as disposable income decreased significantly, but the country is likely to witness an economic boost and higher per capita savings & investment if the large working population is employed.
Many economic reforms have been undertaken to reduce inefficiencies and increase productivity in the country. As of 2021, in Argentina, a total of 1,068,260 noninvasive esthetic procedures were performed of which 158,900 were BoNT treatment, according to International Society of Aesthetic Plastic Surgery.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina botulinum toxin market , including forecasts for subscribers. This country databook contains high-level insights into Argentina botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account